Asthma Treatment and Management

Vocabulary-style flashcards covering the pharmacotherapy and management strategies for asthma as described in the lecture transcript.

SABAs

Short-acting beta-2 agonists, such as albuterol, which work within $15\,\text{minutes}$ and last for $3\text{-}4\,\text{hours}$, helping to manage acute asthma attacks.

LABAs

Long-acting beta agonists, including salmeterol and formoterol, used for severe asthma ideally in combination with inhaled corticosteroids.

IgE

An antibody produced due to exposure to foreign antigens that acts as the primary mediator in allergic asthma.

Albuterol

A prominent beta-2 selective agonist and sympathomimetic agent used to deal with the bronchoconstriction of asthma.

Inhaled corticosteroids

Medications advised for persistent asthma that reduce chronic inflammation by inhibiting the production of inflammatory mediators.

Leukotriene inhibitors

Alternative agents used in asthma management to reduce bronchoconstriction and mucus secretion in the airways.

Theophylline

A medication that aids in bronchial smooth muscle relaxation and inhibits the release of cytokines.

Omalizumab

A monoclonal antibody designed to prevent mast cell activity, which is a critical factor in the pathogenesis of asthma.

Salmeterol and formoterol

Specific examples of long-acting beta agonists (LABAs) used for severe asthma treatment.

Ipratropium bromide

A nebulized agent used as a component of emergent treatment strategies for acute asthma exacerbation.

Epinephrine

An agent administered via subcutaneous or intramuscular routes for severe cases of acute asthma exacerbation.